About This Event

Rocket Pharmaceuticals, Inc. (Nasdaq: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Gaurav Shah, M.D., Chief Executive Officer, Rocket Pharma, rings the Opening Bell.